Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection

Chang Sue Yang; Mei Ju Chen; Ching Kuang Chou; Wen Ming Hsu

doi:10.1159/000088388

Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection

Chang Sue Yang, Mei Ju Chen, Ching Kuang Chou, Wen Ming Hsu

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Purpose: To report a serious complication following intravitreal triamcinolone acetonide injection. Methods: Observational case report. Results: In 2 patients, secondary intractable severe ocular hypertension occurred 2 months after a single 4-mg intravitreal injection of triamcinolone acetonide for macular edema. Both patients required trabeculectomy intervention to control intraocular pressure (IOP). Conclusion: We highlight the occurrence of intractable high IOP elevation as a serious complication 2 months after intravitreal triamcinolone ace- tonide. Cautious monitoring of IOP for several months after this therapy is recommended. The risks of this potentially devastating complication need to be weighed against the benefits of intravitreal triamcinolone in the individual patient.

Original language	English
Pages (from-to)	413-415
Number of pages	3
Journal	Ophthalmologica
Volume	219
Issue number	6
DOIs	https://doi.org/10.1159/000088388
Publication status	Published - Nov 2005
Externally published	Yes

Keywords

Glaucoma
Intraocular pressure
Intravitreal triamcinolone injection

ASJC Scopus subject areas

Sensory Systems
Ophthalmology

Access to Document

10.1159/000088388

Cite this

@article{05c3157380694ae7b690d242218c351d,

title = "Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection",

abstract = "Purpose: To report a serious complication following intravitreal triamcinolone acetonide injection. Methods: Observational case report. Results: In 2 patients, secondary intractable severe ocular hypertension occurred 2 months after a single 4-mg intravitreal injection of triamcinolone acetonide for macular edema. Both patients required trabeculectomy intervention to control intraocular pressure (IOP). Conclusion: We highlight the occurrence of intractable high IOP elevation as a serious complication 2 months after intravitreal triamcinolone ace- tonide. Cautious monitoring of IOP for several months after this therapy is recommended. The risks of this potentially devastating complication need to be weighed against the benefits of intravitreal triamcinolone in the individual patient.",

keywords = "Glaucoma, Intraocular pressure, Intravitreal triamcinolone injection",

author = "Yang, {Chang Sue} and Chen, {Mei Ju} and Chou, {Ching Kuang} and Hsu, {Wen Ming}",

year = "2005",

month = nov,

doi = "10.1159/000088388",

language = "English",

volume = "219",

pages = "413--415",

journal = "Ophthalmologica",

issn = "0030-3755",

publisher = "S. Karger AG",

number = "6",

}

TY - JOUR

T1 - Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection

AU - Yang, Chang Sue

AU - Chen, Mei Ju

AU - Chou, Ching Kuang

AU - Hsu, Wen Ming

PY - 2005/11

Y1 - 2005/11

N2 - Purpose: To report a serious complication following intravitreal triamcinolone acetonide injection. Methods: Observational case report. Results: In 2 patients, secondary intractable severe ocular hypertension occurred 2 months after a single 4-mg intravitreal injection of triamcinolone acetonide for macular edema. Both patients required trabeculectomy intervention to control intraocular pressure (IOP). Conclusion: We highlight the occurrence of intractable high IOP elevation as a serious complication 2 months after intravitreal triamcinolone ace- tonide. Cautious monitoring of IOP for several months after this therapy is recommended. The risks of this potentially devastating complication need to be weighed against the benefits of intravitreal triamcinolone in the individual patient.

AB - Purpose: To report a serious complication following intravitreal triamcinolone acetonide injection. Methods: Observational case report. Results: In 2 patients, secondary intractable severe ocular hypertension occurred 2 months after a single 4-mg intravitreal injection of triamcinolone acetonide for macular edema. Both patients required trabeculectomy intervention to control intraocular pressure (IOP). Conclusion: We highlight the occurrence of intractable high IOP elevation as a serious complication 2 months after intravitreal triamcinolone ace- tonide. Cautious monitoring of IOP for several months after this therapy is recommended. The risks of this potentially devastating complication need to be weighed against the benefits of intravitreal triamcinolone in the individual patient.

KW - Glaucoma

KW - Intraocular pressure

KW - Intravitreal triamcinolone injection

UR - http://www.scopus.com/inward/record.url?scp=27744511943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744511943&partnerID=8YFLogxK

U2 - 10.1159/000088388

DO - 10.1159/000088388

M3 - Article

C2 - 16286805

AN - SCOPUS:27744511943

SN - 0030-3755

VL - 219

SP - 413

EP - 415

JO - Ophthalmologica

JF - Ophthalmologica

IS - 6

ER -

Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this